Join the COVID-19 group to help and get support from people like you.
COVID-19 News (Page 15)
Related terms: 2019-nCoV, 2019 Novel Coronavirus, Coronavirus, SARS-CoV-2 Infection, Novel Coronavirus Pneumonia
Severity of COVID-19 Reinfection Linked to Severity of Initial Infection
THURSDAY, July 18, 2024 – The severity of COVID-19 reinfection seems to be associated with the severity of initial infection, according to a study published online July 11 in Communications...
COVID-19 Infection, Vaccination Not Linked to Congenital Anomalies
FRIDAY, July 19, 2024 – COVID-19 infection and vaccination during the first trimester of pregnancy are not associated with congenital anomalies, according to a study published online July 17 in The...
Fewer Mental Health Facilities Offering Telehealth Since End of Pandemic
FRIDAY, July 19, 2024 – Telehealth availability for mental health services has declined since the end of the COVID-19 public health emergency, according to a study published online July 10 in JAMA ...
Long COVID Risk Has Declined Over the Pandemic and Vaccines May Be Key
THURSDAY, July 18, 2024 – You're far less likely to develop Long COVID now than you were in the midst of the pandemic, promising new data shows. Changes in strains of SARS-CoV-2, the virus that...
Accelerated Progression to T1D During Pandemic Seen for Presymptomatic Youth
THURSDAY, July 18, 2024 – For youth with presymptomatic type 1 diabetes, the COVID-19 pandemic was associated with accelerated progression to clinical disease, especially among those with COVID-19...
Postexposure Prophylaxis With Nirmatrelvir-Ritonavir Does Not Cut COVID-19 Infection
THURSDAY, July 18, 2024 – Postexposure prophylaxis with nirmatrelvir-ritonavir for five or 10 days does not reduce the risk for symptomatic severe acute respiratory syndrome coronavirus 2...
Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity
MONDAY, July 15, 2024 – During the omicron era, hospital-onset severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remained associated with increased morbidity and mortality,...
Long COVID Rates Are Expected to Decline: Study
TUESDAY, July 16, 2024 – People's odds for Long COVID appear to be declining with the advent of new variants of the virus, along with repeat infections and vaccinations, new research shows. That...
Global Childhood Vaccination Rates Still Haven't Recovered from Pandemic Declines
MONDAY, July 15, 2024 – More than four years after the pandemic began, childhood vaccination rates worldwide have yet to recover, a new report shows. The latest data, issued Monday by the World...
Nearly 1 in 10 Pregnant Women Who Get COVID Develop Long COVID
FRIDAY, July 12, 2025 – Almost 10% of women who get COVID during pregnancy develop long-lasting symptoms, and a new study suggests doctors may be overlooking them. "I doubt most obstetric clinicians...
FDA Medwatch Alert: FDA Safety Communication: Do Not Use Cue Health’s COVID-19 Tests Due to Risk of False Results
May 13, 2024 – The U.S. Food and Drug Administration (FDA) is warning home test users, caregivers, and health care providers not to use Cue Health’s COVID-19 Tests for Home and Over-the-Counter (...
Invivyd Announces FDA Authorization for Emergency Use of Pemgarda (Formerly VYD222) for Pre-Exposure Prophylaxis (PrEP) of COVID-19
WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) – Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today...
FDA Medwatch Alert: Important Information About the Correct Dosage and Administration of Moderna COVID-19 Vaccine (2023-2024 Formula) for Individuals 6 Months Through 11 Years of Age
November 1, 2023 – The Food and Drug Administration (FDA) is advising healthcare providers who administer the Moderna COVID-19 Vaccine (2023-2024 Formula) to individuals 6 months through 11 years of...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
Clinical data show robust immune responses across multiple circulating variants, including EG.5, FL.1.5.1, and BA.2.86 Updated vaccine to be available in pharmacies and care settings across the U.S....
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
This season’s vaccine is tailored to the SARS-CoV-2 XBB.1.5 sublineage and indicated as a single dose for most individuals 5 years of age and older Pre-clinical data show that the updated COVID-19 v...